Indivior (LON:INDV) Shares Down 21.3% - Here's Why

Indivior PLC (LON:INDV - Get Free Report) fell 21.3% on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 683 ($8.63). 1,971,282 shares were traded during trading, an increase of 177% from the average session volume of 711,780 shares. The stock had previously closed at GBX 868 ($10.97).

Analysts Set New Price Targets

Separately, Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 1,800 ($22.74) target price on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Trading Down 5.9 %

The business's 50 day simple moving average is GBX 920.11 and its two-hundred day simple moving average is GBX 850.81. The stock has a market cap of £1.08 billion, a P/E ratio of -570.87, a PEG ratio of -5.57 and a beta of 0.19. The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.